Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial
Stephen R. Walsh(Beth Israel Deaconess Medical Center), Lindsey R. Baden(Brigham and Women's Hospital), Kelly Verrill(Dana-Farber Brigham Cancer Center), Aruna Acharyya(Emmes (United States)), Shringkhala Bajimaya(Beth Israel Deaconess Medical Center), Lisa S. Gagne(Brigham and Women's Hospital), Joseph H. Antin(Dana-Farber Cancer Institute), Elise Zablowsky(Herzog Hospital), Michael S. Seaman(Beth Israel Deaconess Medical Center), Marissa B. Wilck(Brigham and Women's Hospital), David C. Fisher(Dana-Farber Cancer Institute), Ying Zhang(Second Affiliated Hospital of Guangzhou Medical University), Heather Hill(Emmes (United States)), Raphael Dolin(Beth Israel Deaconess Medical Center), Jane A. Kleinjan(Brigham and Women's Hospital), Alka Patel, David J. Dominguez(Beth Israel Deaconess Medical Center)
Cited by 76
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981